VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


Is BRCA1/2 Genetic Counseling by Telephone Inferior to a Face-to-face Interaction?

Is BRCA1/2 Genetic Counseling by Telephone Inferior to a Face-to-face Interaction?

Telephone interviews to deliver genetic counseling may be non-inferior to in-person counseling.

Some Patients With Endocrine-responsive Early-stage Breast Cancer May Avoid Chemotherapy

Some Patients With Endocrine-responsive Early-stage Breast Cancer May Avoid Chemotherapy

Several adjuvant endocrine therapy options are available for premenopausal patients with endocrine-responsive early-stage breast cancer.

Era of Precision Oncology for Prostate Cancer 'Is Upon Us'

Era of Precision Oncology for Prostate Cancer 'Is Upon Us'

New biomarkers might revolutionize prostate cancer treatment, according to an educational presentation at the 2016 ASCO Annual Meeting in Chicago.

Aggressive Local Therapies Improve Survival for Limited-metastatic NSCLC

Aggressive Local Therapies Improve Survival for Limited-metastatic NSCLC

Local treatment may provide a survival benefit for patients with metastatic non-small cell lung cancer (NSCLC).

Immunotherapy Offers Promise for Patients with Recurrent and Metastatic Head and Neck Cancer

Immunotherapy Offers Promise for Patients with Recurrent and Metastatic Head and Neck Cancer

At the 2016 ASCO Annual Meeting, presenters discussed the current state and future of immune therapy for patients with head and neck cancer.

Some Patients With Locally Advanced Rectal Cancer May Avoid Surgery

Some Patients With Locally Advanced Rectal Cancer May Avoid Surgery

Some patients with rectal cancer who experience complete clinical response after neoadjuvant therapy may safely avoid total mesorectal excision.

Artificial Intelligence May Help Improve Accuracy of Cancer Diagnoses

Artificial Intelligence May Help Improve Accuracy of Cancer Diagnoses

Harvard researchers are developing a machine-learning algorithm, using a "deep learning" approach, which interprets complex patterns observed in real-life data by building multi-layered artificial neural networks, in an attempt to refine AI-based cancer diagnoses.

Research Suggests That Multiple Myeloma Is Heritable

Research Suggests That Multiple Myeloma Is Heritable

Oncologists may be on the path towards elucidating clinically translatable etiologies of MM.

Numerous Factors Contribute to Gender-based Disparity of Bladder Cancer Survival

Numerous Factors Contribute to Gender-based Disparity of Bladder Cancer Survival

Access to chemotherapy is just 1 of many factors influencing disparities of survival rates among men and women diagnosed with bladder cancer.

Radio/Immunotherapy Combination May Be Effective on Specific Tumor Types

Radio/Immunotherapy Combination May Be Effective on Specific Tumor Types

A combination of radiotherapy with local and systemic immunotherapy may be clinically beneficial for treating some types of tumors.

Novel Agents Show Promise Against Endocrine-resistant Breast Cancer

Novel Agents Show Promise Against Endocrine-resistant Breast Cancer

Several novel agents, including checkpoint inhibitors, are being tested and may soon be approved for the treatment of metastatic breast cancer.

Should Oncology Drug Trials Rely Less on Overall Survival?

Should Oncology Drug Trials Rely Less on Overall Survival?

Calls for wider adoption of surrogate survival measures as clinical trial endpoints should be considered cautiously; physicians should carefully consider—and communicate to patients—clinical trials' endpoints.

Males With Recurrent Breast Cancer at Greater Risk of Mortality Than Females

Males With Recurrent Breast Cancer at Greater Risk of Mortality Than Females

Males with breast cancer are less likely to survive than females after disease recurrence, which may be due to less aggressive treatment after relapse.

Inotuzumab Ozogamicin May Improve Survival for Patients With Acute Lymphoblastic Leukemia

Inotuzumab Ozogamicin May Improve Survival for Patients With Acute Lymphoblastic Leukemia

Patients with ALL treated with the monoclonal antibody inotuzumab ozogamicin were more likely to proceed to stem cell transplantation.

Significant Variations May Exist in Treatment Practices for Multiple Myeloma

Significant Variations May Exist in Treatment Practices for Multiple Myeloma

A cross-sectional study of treatments for MM across several European countries suggests consistency in agents used as first-line and second-line treatments, though there are disparities among later treatments.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters